HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Tian Selected Research

mono-PEGylated Endostar

4/2010Characterization of a monoPEG20000-Endostar.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Tian Research Topics

Disease

21Infections
02/2022 - 12/2003
10Neoplasms (Cancer)
01/2022 - 09/2012
8Body Weight (Weight, Body)
01/2022 - 12/2003
8Retinal Neovascularization
01/2022 - 01/2017
7Male Infertility (Male Sterility)
01/2019 - 11/2006
5Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2022 - 01/2017
5Inflammation (Inflammations)
01/2020 - 10/2012
5Pain (Aches)
11/2019 - 03/2017
4Choroidal Neovascularization
01/2022 - 11/2017
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 01/2017
4Virus Diseases (Viral Diseases)
01/2022 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
01/2020 - 09/2010
4Leukemia
01/2016 - 06/2005
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2014 - 08/2002
4Varicocele
10/2012 - 11/2006
4Infertility (Sterility)
11/2009 - 11/2006
3Pathologic Neovascularization
01/2022 - 01/2018
3Blindness (Hysterical Blindness)
01/2022 - 05/2021
3Hyperalgesia
10/2018 - 09/2017
3Neuralgia (Stump Neuralgia)
10/2018 - 09/2017
3Hypoxia (Hypoxemia)
02/2016 - 02/2003
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2013 - 03/2007
3Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2008 - 08/2002
2Obesity
01/2022 - 01/2016
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2014
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 08/2002
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2020
2Residual Neoplasm
01/2022 - 11/2021
2Multiple Myeloma
01/2022 - 10/2021
2Chronic Obstructive Pulmonary Disease (COPD)
08/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
07/2021 - 09/2006
2Meige Syndrome
05/2021 - 01/2019
2Vascular Diseases (Vascular Disease)
05/2021 - 11/2017
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 11/2019
2Mitochondrial Diseases (Mitochondrial Disease)
12/2020 - 11/2020
2Fibrosis (Cirrhosis)
01/2020 - 01/2020
2Lung Neoplasms (Lung Cancer)
01/2018 - 04/2010
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2016 - 11/2009
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 04/2012
2Stroke (Strokes)
01/2016 - 01/2014
2Cerebral Infarction
01/2016 - 11/2009
2Hematologic Neoplasms (Hematological Malignancy)
10/2013 - 08/2002
2Brain Ischemia (Cerebral Ischemia)
11/2009 - 10/2009
2Brain Injuries (Brain Injury)
11/2009 - 10/2009
2Vasovagal Syncope
07/2009 - 08/2008
2Syncope (Fainting)
07/2009 - 08/2008

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
02/2022 - 11/2006
8Retinaldehyde (Retinal)IBA
01/2022 - 01/2017
7secretogranin IIIIBA
01/2022 - 01/2017
7Pharmaceutical PreparationsIBA
01/2022 - 01/2015
6VaccinesIBA
02/2022 - 06/2010
6Peptides (Polypeptides)IBA
01/2022 - 10/2013
6Messenger RNA (mRNA)IBA
08/2021 - 12/2003
6Biomarkers (Surrogate Marker)IBA
08/2021 - 02/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2009
5Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2022 - 01/2018
5Monoclonal AntibodiesIBA
01/2022 - 01/2019
5AntibodiesIBA
01/2022 - 06/2010
5Oxygen (Dioxygen)IBA
01/2019 - 02/2016
4Blood Glucose (Blood Sugar)IBA
01/2022 - 06/2013
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2015
4MicroRNAs (MicroRNA)IBA
08/2021 - 01/2014
4Streptozocin (Streptozotocin)FDA Link
12/2020 - 03/2007
4CytokinesIBA
01/2020 - 01/2013
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2016 - 08/2002
4AntigensIBA
10/2013 - 03/2008
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 09/2010
3Antiviral Agents (Antivirals)IBA
01/2021 - 01/2017
3Neutralizing AntibodiesIBA
08/2019 - 11/2017
3EpitopesIBA
01/2019 - 01/2014
3Ubiquitin-Specific ProteasesIBA
01/2019 - 11/2007
3Interleukin-6 (Interleukin 6)IBA
01/2018 - 10/2012
3RivaroxabanIBA
01/2018 - 02/2011
2afliberceptIBA
01/2022 - 01/2022
2Proteasome InhibitorsIBA
01/2022 - 10/2021
2Interferon Type IIBA
01/2022 - 01/2019
2Polysaccharides (Glycans)IBA
07/2021 - 03/2007
2LipidsIBA
12/2020 - 01/2016
2LigandsIBA
01/2020 - 01/2017
2ChemokinesIBA
01/2020 - 01/2020
2Hormones (Hormone)IBA
01/2019 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2018 - 08/2013
2CalciumIBA
01/2018 - 11/2009
2CanagliflozinIBA
01/2016 - 01/2015
2Tyrosine (L-Tyrosine)FDA Link
02/2014 - 06/2009
2CollagenIBA
08/2013 - 12/2003
2Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2009 - 10/2009
2DNA (Deoxyribonucleic Acid)IBA
06/2005 - 02/2003

Therapy/Procedure

17Therapeutics
01/2022 - 06/2008
4Hematopoietic Stem Cell Transplantation
01/2022 - 02/2014
4Drug Therapy (Chemotherapy)
01/2016 - 08/2002
3Transplantation
01/2022 - 12/2003
2Oral Administration
01/2022 - 01/2020
2Intravitreal Injections
01/2022 - 11/2017
2Lasers (Laser)
01/2022 - 11/2017
2Induction Chemotherapy
11/2021 - 01/2016
2Deep Brain Stimulation
05/2021 - 01/2019
2Ligation
01/2020 - 01/2016
2Spinal Injections
10/2018 - 09/2017
2Immunotherapy
05/2017 - 10/2013